BenchSci

About BenchSci

BenchSci is a company focused on reimagining research through its Disease Biology Generative AI Platform for Pharma R&D called ASCEND. ASCEND serves as an AI assistant and co-pilot for preclinical scientists, enhancing biology-related decision-making, uncovering novelty, and increasing experimental productivity in drug discovery.

Products & Services

ASCEND:A science-first Generative AI R&D Platform designed to unravel disease biology. It acts as an AI assistant/co-pilot for scientists, leveraging a knowledge graph and ontological base to guide research, improve decision-making, and enhance experimental productivity. Features include robust data foundations, pharma-focused AI assistants, and enterprise-ready integrations.

Specialties

Generative AI for Pharma R&D Disease Biology Drug Discovery Multi-modal AI Knowledge Graph and Ontology Pharma Workflow Integration

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series D T: - FT: Series D	A: 70000000 MR: - FA: $95 million FAN: 70000000	D: 2023-05-25 FD: 2023-05-25	5 investors

Series D Latest

2023-05-25

$70.0M

5 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Matt Truppo

Global Head of Research Platforms for Sanofi

P

Philip Larsen

Former SVP and Global Head of Research

P

Philip Tagari

Former VP of Research (Therapeutic Discovery)

S

Scott Oloff

SVP and Global Head of Data and Analytics

S

Steve Hitchcock

Former Chief Scientific Officer

S

Sylke Poehling

SVP and Global Head of Therapeutic Modalities

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

BenchSci Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised